Day: August 13, 2024

WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and up to $200,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”). The funding will be received over a period of 20 months and will support the development of three additional products to build on Kane Biotech’s revyveTM Antimicrobial Wound Gel technology. The Company expects to be able to leverage its newly expanded US Food and Drug Administration (“FDA”) 510(k) clearance for its revyveTM Antimicrobial Wound Gel.(1) revyveTM Antimicrobial Wound Gel Spray: Will provide ease of use and is optimized for sensitive wounds like first-second degree burns and venous...

For the Third Consecutive Year, ConnectM Earns a Spot on the Inc. 5000 Achieving Three-Year Revenue Growth of 1,200% NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) — Inc. announced today that ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) (“ConnectM”), a technology company focused on the electrification economy, has secured the No. 104 spot on its prestigious Inc. 5000 list, which ranks the fastest-growing private companies in America. In addition, ConnectM ranked No. 5 among energy companies and No. 4 in Massachusetts. This recognition highlights ConnectM’s exceptional growth and innovation within the technology sector, marking its third consecutive year on this esteemed list.  Over the past three years, ConnectM has achieved remarkable growth of 1,200%. In 2023, the company ranked No. 636 with a 916% revenue increase...

Urges Stockholders to Reduce Solicitation Costs by Voting their Shares Immediately NEW YORK, NY, Aug. 13, 2024 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE: SAR) (“Saratoga Investment,” “Saratoga” or “the Company”) today announced that the Company commenced distribution of proxy materials to the Company’s stockholders for the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on September 26 2024. Saratoga’s Annual Report on Form 10-K for the year ended February 29, 2024, and its definitive proxy statement for the Annual Meeting which was filed on August 1, 2024 with the U.S. Securities and Exchange Commission, may be viewed on Saratoga’s Investor Relations website at https://ir.saratogainvestmentcorp.com/financial-informations. Your vote is important regardless of the number of shares you own. The Company’s...

Based on Merits of the Case, Company Received Multiple Offers to Fund Lawsuit Filed on November 10, 2022 LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, received multiple offers to fund its lawsuit on a non-recourse non-dilutive basis based on the merits of its legal case. The Company entered into an agreement with a well-known alternative asset investment firm and the Company’s litigation counsel, Boesch Law Group, to provide non-recourse non-dilutive litigation financing. Barfresh has spent approximately $300,000 over the past two years for this lawsuit which affected its operating margins. This new non-recourse non-dilutive financing removes the need for additional cash from the Company to fund...

RONAN, Mont., Aug. 13, 2024 (GLOBE NEWSWIRE) — Montana Technologies Corporation (NASDAQ: AIRJ), (“Montana Technologies” or the “Company”), the developer of the transformational AirJoule® technology for atmospheric water generation, today announced it will be restating its previously issued unaudited financial statements for the three months ended March 31, 2024. Investors should no longer rely upon the previously issued financial statements cited above. Similarly, any earnings releases and other investor communications derived from such financial statements should no longer be relied upon. The Company’s Board of Directors, in consultation with management and upon the recommendation of the Audit Committee of the Board of Directors, made the decision to restate the first quarter financial statements following the results of a Company-initiated...

LARGO, Fla., Aug. 13, 2024 (GLOBE NEWSWIRE) — NAPC Defense, Inc., (OTCPK: BLIS) (“NAPC” or “the Company”) announces that its representatives have returned from their meetings with interested parties in Europe and Saudi Arabia, concerning its CornerShot products, various munitions, and other military hardware. The NAPC representatives made progress with their Saudi Arabian counterparts and the potential for proposed contracts remains promising. NAPC received a $253,000 Purchase Order to support technical activity and expertise for CornerShot, drones, and other munitions. This support requires sending in country personnel to assist the Saudi Ministry of Defense (“MOD”) with technical questions and training.Pictured from left to right are John Spence, NAPC CFO, Stephen Gurba, NAPC President, Eng. Abdullah Mohamed Al Bassami, and...

                Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8 million in cash         TORONTO, ONTARIO, Aug. 13, 2024 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today reported its financial and operating results for the quarter ended June 30, 2024 and provided a corporate update. “We are very pleased with the ongoing post-merger integration process and expect to be providing a fulsome update shortly. The newly combined management team is currently completing our detailed work to identify synergies...